The Botulinum J.

Units, weights and concentrations: the botulinum toxin dilemma
pp. 4-5(2)
Author: Pickett, Andrew

A pilot trial of onabotulinumtoxinA for the treatment of cervicothoracic myofascial pain
pp. 6-15(10)
Authors: Davis, Thomas L.; Fang, John Y.; Gill, Chandler E.; Charles, P. David

Novel benzimidazole inhibitors of botulinum neurotoxin/A display enzyme and cell-based potency
pp. 16-29(14)
Authors: Cardinale, Steven C.; Butler, Michelle M.; Ruthel, Gordon; Nuss, Jonathan E.; Wanner, Laura M.; Li, Bing; Pai, Ramdas P.; Peet, Norton P.; Bavari, Sina; Bowlin, Terry L.

Enhanced sensitivity to Botulinum type A neurotoxin of human neuroblastoma SH-SY5Y cells after differentiation into mature neuronal cells
pp. 30-48(19)
Authors: Rasetti-Escargueil, C.; Machado, C.B.; Preneta-Blanc, R.; Fleck, R.A.; Sesardic, D.

Stability of botulinum neurotoxin type A, devoid of complexing proteins
pp. 49-58(10)
Authors: Grein, Swen; Mander, Gerd J.; Fink, Klaus

Evaluation of anti-hemagglutinin Hn-33 single domain antibodies: kinetics, binding epitopes, and thermal stability
pp. 59-71(13)
Authors: Anderson, George P.; Zabetakis, Dan; Bernstein, Rachael D.; Cai, Shuowei; Singh, Bal Ram; Goldman, Ellen R.

Utility of Botulinum Toxin ELISA A, B, E, F kits for clinical laboratory investigations of human botulism
pp. 72-92(21)
Authors: Maslanka, Susan E.; Luquez, Carolina; Raphael, Brian H.; Dykes, Janet K.; Joseph, Lavin A.